Table 2.

Multivariate risk factors for survival among 84 HIV-HNC patients with data on survival and tumor stage (33 of whom also had data on tumor HPV status).

	Including tumor stage and HPV Status			Final Model
Variable at cancer diagnosis	Hazard Ratio	P value	95% CI	Hazard Ratio	P value	95% CI
CD4 cell count
≥200	1.00			1.00
100–199	1.18	0.802	(0.32–4.42)	1.22	0.742	(0.38,3.90)
<100	3.09	0.025	(1.15–8.30)	2.52	0.036	(1.06,6.0)
Unknown	3.29	0.019	(1.22,8.87)	1.68	0.225	(0.73,3.88)
Tumor Site
Oropharynx	1.00			1.00
Oral Cavity	1.35	0.582	(0.46,3.91)	1.03	0.949	(0.44,2.40)
Larynx/HP/HNC multisite	3.54	0.011	(1.34,9.35)	3.12	0.008	(1.35,7.23)
Race/Ethnicity
White non-Hispanic	1.00			1.00
Black NH or Hispanic any race	2.02	0.093	(0.89,4.58)	2.73	0.008	(1.30,5.76)
Current Tobacco Use
Current smoking status	2.54	0.062	(0.96,6.76)	1.92	0.083	(0.92,4.03)
Cancer Stage
1–2	1.00
3–4	1.46	0.571	(0.40,5.32)
Tumor HPV Status
Negative	1.00
Positive	0.87	0.832	(0.23,3.25)
Unknown Status (not tested)	1.18	0.696	(0.51,2.74)